FDA Presses Clinical Hold Button For BioNTech's Partner Late-Stage Trial Of Investigational Lung Cancer Treatment — Oct 21st, 2024

FDA Presses Clinical Hold Button For BioNTech's Partner Late-Stage Trial Of Investigational Lung Cancer Treatment BioNTech SE (NASDAQ:BNTX) has been notified by its partner, OncoC4 Inc., that the FDA has imposed a partial clinical hold on its Phase 3 PRESERVE-003 trial. The open-label, r...

BioNTech Nears A Sell Signal After Cutting Outlook Despite Massive Sales Beat — Nov 4th, 2024

BioNTech stock reversed lower Monday after the company cut its outlook for the year, despite walloping sales estimates. Continue reading View comments...

Vaccine Stocks Drop on Worries About an RFK Jr. Role — Nov 6th, 2024

It’s too early to know if Robert F. Kennedy Jr. will have an important healthcare role in a second Trump administration, but investors in vaccine stocks are already taking cover. Donald Trump said on Tuesday that Kennedy, an anti-vaccine activist, could “do pretty much what he wants”...

BioNTech Nears A Sell Signal After Cutting Outlook Despite Massive Sales Beat — Nov 4th, 2024

BioNTech stock reversed lower Monday after the company cut its outlook for the year, despite walloping sales estimates. Continue reading View comments...

Vaccine Stocks Drop on Worries About an RFK Jr. Role — Nov 6th, 2024

It’s too early to know if Robert F. Kennedy Jr. will have an important healthcare role in a second Trump administration, but investors in vaccine stocks are already taking cover. Donald Trump said on Tuesday that Kennedy, an anti-vaccine activist, could “do pretty much what he wants”...

Vaccine Stocks Drop on Worries About an RFK Jr. Role — Nov 6th, 2024

It’s too early to know if Robert F. Kennedy Jr. will have an important healthcare role in a second Trump administration, but investors in vaccine stocks are already taking cover. Donald Trump said on Tuesday that Kennedy, an anti-vaccine activist, could “do pretty much what he wants”...

Vaccine Stocks Drop on Worries About an RFK Jr. Role — Nov 6th, 2024

It’s too early to know if Robert F. Kennedy Jr. will have an important healthcare role in a second Trump administration, but investors in vaccine stocks are already taking cover. Donald Trump said on Tuesday that Kennedy, an anti-vaccine activist, could “do pretty much what he wants”...

BioNTech Nears A Sell Signal After Cutting Outlook Despite Massive Sales Beat — Nov 4th, 2024

BioNTech stock reversed lower Monday after the company cut its outlook for the year, despite walloping sales estimates. Continue reading View comments...

Vaccine Stocks Drop on Worries About an RFK Jr. Role — Nov 6th, 2024

It’s too early to know if Robert F. Kennedy Jr. will have an important healthcare role in a second Trump administration, but investors in vaccine stocks are already taking cover. Donald Trump said on Tuesday that Kennedy, an anti-vaccine activist, could “do pretty much what he wants”...

BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It. — Nov 19th, 2024

BioNTech stock has tumbled since President-elect Donald Trump tapped Robert F. Kennedy Jr. to lead the Department of Health and Human Services, but one analyst now sees a buying opportunity. Evercore ISI analyst Cory Kasimov upgraded the German drugmaker’s stock to Outperform from In Lin...

FDA Presses Clinical Hold Button For BioNTech's Partner Late-Stage Trial Of Investigational Lung Cancer Treatment — Oct 21st, 2024

FDA Presses Clinical Hold Button For BioNTech's Partner Late-Stage Trial Of Investigational Lung Cancer Treatment BioNTech SE (NASDAQ:BNTX) has been notified by its partner, OncoC4 Inc., that the FDA has imposed a partial clinical hold on its Phase 3 PRESERVE-003 trial. The open-label, r...

BioNTech Nears A Sell Signal After Cutting Outlook Despite Massive Sales Beat — Nov 4th, 2024

BioNTech stock reversed lower Monday after the company cut its outlook for the year, despite walloping sales estimates. Continue reading View comments...

BioNTech Nears A Sell Signal After Cutting Outlook Despite Massive Sales Beat — Nov 4th, 2024

BioNTech stock reversed lower Monday after the company cut its outlook for the year, despite walloping sales estimates. Continue reading View comments...

FDA Presses Clinical Hold Button For BioNTech's Partner Late-Stage Trial Of Investigational Lung Cancer Treatment — Oct 21st, 2024

FDA Presses Clinical Hold Button For BioNTech's Partner Late-Stage Trial Of Investigational Lung Cancer Treatment BioNTech SE (NASDAQ:BNTX) has been notified by its partner, OncoC4 Inc., that the FDA has imposed a partial clinical hold on its Phase 3 PRESERVE-003 trial. The open-label, r...

Vaccine Stocks Drop on Worries About an RFK Jr. Role — Nov 6th, 2024

It’s too early to know if Robert F. Kennedy Jr. will have an important healthcare role in a second Trump administration, but investors in vaccine stocks are already taking cover. Donald Trump said on Tuesday that Kennedy, an anti-vaccine activist, could “do pretty much what he wants”...

BioNTech Nears A Sell Signal After Cutting Outlook Despite Massive Sales Beat — Nov 4th, 2024

BioNTech stock reversed lower Monday after the company cut its outlook for the year, despite walloping sales estimates. Continue reading View comments...

Vaccine Stocks Drop on Worries About an RFK Jr. Role — Nov 6th, 2024

It’s too early to know if Robert F. Kennedy Jr. will have an important healthcare role in a second Trump administration, but investors in vaccine stocks are already taking cover. Donald Trump said on Tuesday that Kennedy, an anti-vaccine activist, could “do pretty much what he wants”...

BioNTech Nears A Sell Signal After Cutting Outlook Despite Massive Sales Beat — Nov 4th, 2024

BioNTech stock reversed lower Monday after the company cut its outlook for the year, despite walloping sales estimates. Continue reading View comments...

BioNTech Nears A Sell Signal After Cutting Outlook Despite Massive Sales Beat — Nov 4th, 2024

BioNTech stock reversed lower Monday after the company cut its outlook for the year, despite walloping sales estimates. Continue reading View comments...

BioNTech Nears A Sell Signal After Cutting Outlook Despite Massive Sales Beat — Nov 4th, 2024

BioNTech stock reversed lower Monday after the company cut its outlook for the year, despite walloping sales estimates. Continue reading View comments...

BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024 — Oct 21st, 2024

BioNTech SE MAINZ, Germany, October 21, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter 2024 on Monday, November 4, 2024. Additionally, the Company will host a conference call and webcast t...

BioNTech Nears A Sell Signal After Cutting Outlook Despite Massive Sales Beat — Nov 4th, 2024

BioNTech stock reversed lower Monday after the company cut its outlook for the year, despite walloping sales estimates. Continue reading View comments...

Vaccine Stocks Drop on Worries About an RFK Jr. Role — Nov 6th, 2024

It’s too early to know if Robert F. Kennedy Jr. will have an important healthcare role in a second Trump administration, but investors in vaccine stocks are already taking cover. Donald Trump said on Tuesday that Kennedy, an anti-vaccine activist, could “do pretty much what he wants”...

BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It. — Nov 19th, 2024

BioNTech stock has tumbled since President-elect Donald Trump tapped Robert F. Kennedy Jr. to lead the Department of Health and Human Services, but one analyst now sees a buying opportunity. Evercore ISI analyst Cory Kasimov upgraded the German drugmaker’s stock to Outperform from In Lin...

BioNTech Nears A Sell Signal After Cutting Outlook Despite Massive Sales Beat — Nov 4th, 2024

BioNTech stock reversed lower Monday after the company cut its outlook for the year, despite walloping sales estimates. Continue reading View comments...

BioNTech Nears A Sell Signal After Cutting Outlook Despite Massive Sales Beat — Nov 4th, 2024

BioNTech stock reversed lower Monday after the company cut its outlook for the year, despite walloping sales estimates. Continue reading View comments...

BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It. — Nov 19th, 2024

BioNTech stock has tumbled since President-elect Donald Trump tapped Robert F. Kennedy Jr. to lead the Department of Health and Human Services, but one analyst now sees a buying opportunity. Evercore ISI analyst Cory Kasimov upgraded the German drugmaker’s stock to Outperform from In Lin...

BioNTech Nears A Sell Signal After Cutting Outlook Despite Massive Sales Beat — Nov 4th, 2024

BioNTech stock reversed lower Monday after the company cut its outlook for the year, despite walloping sales estimates. Continue reading View comments...

BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It. — Nov 19th, 2024

BioNTech stock has tumbled since President-elect Donald Trump tapped Robert F. Kennedy Jr. to lead the Department of Health and Human Services, but one analyst now sees a buying opportunity. Evercore ISI analyst Cory Kasimov upgraded the German drugmaker’s stock to Outperform from In Lin...

Vaccine Stocks Drop on Worries About an RFK Jr. Role — Nov 6th, 2024

It’s too early to know if Robert F. Kennedy Jr. will have an important healthcare role in a second Trump administration, but investors in vaccine stocks are already taking cover. Donald Trump said on Tuesday that Kennedy, an anti-vaccine activist, could “do pretty much what he wants”...

BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It. — Nov 19th, 2024

BioNTech stock has tumbled since President-elect Donald Trump tapped Robert F. Kennedy Jr. to lead the Department of Health and Human Services, but one analyst now sees a buying opportunity. Evercore ISI analyst Cory Kasimov upgraded the German drugmaker’s stock to Outperform from In Lin...

Vaccine Stocks Drop on Worries About an RFK Jr. Role — Nov 6th, 2024

It’s too early to know if Robert F. Kennedy Jr. will have an important healthcare role in a second Trump administration, but investors in vaccine stocks are already taking cover. Donald Trump said on Tuesday that Kennedy, an anti-vaccine activist, could “do pretty much what he wants”...

Vaccine Stocks Drop on Worries About an RFK Jr. Role — Nov 6th, 2024

It’s too early to know if Robert F. Kennedy Jr. will have an important healthcare role in a second Trump administration, but investors in vaccine stocks are already taking cover. Donald Trump said on Tuesday that Kennedy, an anti-vaccine activist, could “do pretty much what he wants”...

Vaccine Stocks Drop on Worries About an RFK Jr. Role — Nov 6th, 2024

It’s too early to know if Robert F. Kennedy Jr. will have an important healthcare role in a second Trump administration, but investors in vaccine stocks are already taking cover. Donald Trump said on Tuesday that Kennedy, an anti-vaccine activist, could “do pretty much what he wants”...

BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It. — Nov 19th, 2024

BioNTech stock has tumbled since President-elect Donald Trump tapped Robert F. Kennedy Jr. to lead the Department of Health and Human Services, but one analyst now sees a buying opportunity. Evercore ISI analyst Cory Kasimov upgraded the German drugmaker’s stock to Outperform from In Lin...

BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024 — Oct 21st, 2024

BioNTech SE MAINZ, Germany, October 21, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter 2024 on Monday, November 4, 2024. Additionally, the Company will host a conference call and webcast t...

FDA Presses Clinical Hold Button For BioNTech's Partner Late-Stage Trial Of Investigational Lung Cancer Treatment — Oct 21st, 2024

FDA Presses Clinical Hold Button For BioNTech's Partner Late-Stage Trial Of Investigational Lung Cancer Treatment BioNTech SE (NASDAQ:BNTX) has been notified by its partner, OncoC4 Inc., that the FDA has imposed a partial clinical hold on its Phase 3 PRESERVE-003 trial. The open-label, r...

Vaccine Stocks Drop on Worries About an RFK Jr. Role — Nov 6th, 2024

It’s too early to know if Robert F. Kennedy Jr. will have an important healthcare role in a second Trump administration, but investors in vaccine stocks are already taking cover. Donald Trump said on Tuesday that Kennedy, an anti-vaccine activist, could “do pretty much what he wants”...

BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It. — Nov 19th, 2024

BioNTech stock has tumbled since President-elect Donald Trump tapped Robert F. Kennedy Jr. to lead the Department of Health and Human Services, but one analyst now sees a buying opportunity. Evercore ISI analyst Cory Kasimov upgraded the German drugmaker’s stock to Outperform from In Lin...

BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It. — Nov 19th, 2024

BioNTech stock has tumbled since President-elect Donald Trump tapped Robert F. Kennedy Jr. to lead the Department of Health and Human Services, but one analyst now sees a buying opportunity. Evercore ISI analyst Cory Kasimov upgraded the German drugmaker’s stock to Outperform from In Lin...

BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It. — Nov 19th, 2024

BioNTech stock has tumbled since President-elect Donald Trump tapped Robert F. Kennedy Jr. to lead the Department of Health and Human Services, but one analyst now sees a buying opportunity. Evercore ISI analyst Cory Kasimov upgraded the German drugmaker’s stock to Outperform from In Lin...

BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It. — Nov 19th, 2024

BioNTech stock has tumbled since President-elect Donald Trump tapped Robert F. Kennedy Jr. to lead the Department of Health and Human Services, but one analyst now sees a buying opportunity. Evercore ISI analyst Cory Kasimov upgraded the German drugmaker’s stock to Outperform from In Lin...

BioNTech Nears A Sell Signal After Cutting Outlook Despite Massive Sales Beat — Nov 4th, 2024

BioNTech stock reversed lower Monday after the company cut its outlook for the year, despite walloping sales estimates. Continue reading View comments...

BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024 — Oct 21st, 2024

BioNTech SE MAINZ, Germany, October 21, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter 2024 on Monday, November 4, 2024. Additionally, the Company will host a conference call and webcast t...

BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024 — Oct 21st, 2024

BioNTech SE MAINZ, Germany, October 21, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter 2024 on Monday, November 4, 2024. Additionally, the Company will host a conference call and webcast t...

BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It. — Nov 19th, 2024

BioNTech stock has tumbled since President-elect Donald Trump tapped Robert F. Kennedy Jr. to lead the Department of Health and Human Services, but one analyst now sees a buying opportunity. Evercore ISI analyst Cory Kasimov upgraded the German drugmaker’s stock to Outperform from In Lin...

BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It. — Nov 19th, 2024

BioNTech stock has tumbled since President-elect Donald Trump tapped Robert F. Kennedy Jr. to lead the Department of Health and Human Services, but one analyst now sees a buying opportunity. Evercore ISI analyst Cory Kasimov upgraded the German drugmaker’s stock to Outperform from In Lin...

Vaccine Stocks Drop on Worries About an RFK Jr. Role — Nov 6th, 2024

It’s too early to know if Robert F. Kennedy Jr. will have an important healthcare role in a second Trump administration, but investors in vaccine stocks are already taking cover. Donald Trump said on Tuesday that Kennedy, an anti-vaccine activist, could “do pretty much what he wants”...

BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It. — Nov 19th, 2024

BioNTech stock has tumbled since President-elect Donald Trump tapped Robert F. Kennedy Jr. to lead the Department of Health and Human Services, but one analyst now sees a buying opportunity. Evercore ISI analyst Cory Kasimov upgraded the German drugmaker’s stock to Outperform from In Lin...

BioNTech Stock Has Been Hit Hard Since RFK Jr.’s Nomination. Why This Analyst Upgraded It. — Nov 19th, 2024

BioNTech stock has tumbled since President-elect Donald Trump tapped Robert F. Kennedy Jr. to lead the Department of Health and Human Services, but one analyst now sees a buying opportunity. Evercore ISI analyst Cory Kasimov upgraded the German drugmaker’s stock to Outperform from In Lin...